Ascendis Pharma A (ASND) Inventory Average (2022 - 2025)
Ascendis Pharma A (ASND) has disclosed Inventory Average for 4 consecutive years, with $333.4 million as the latest value for Q4 2025.
- Quarterly Inventory Average rose 23.34% to $333.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $333.4 million through Dec 2025, up 23.34% year-over-year, with the annual reading at $333.4 million for FY2025, 23.34% up from the prior year.
- Inventory Average hit $333.4 million in Q4 2025 for Ascendis Pharma A, up from $270.3 million in the prior quarter.
- In the past five years, Inventory Average ranged from a high of $333.4 million in Q4 2025 to a low of $109.8 million in Q4 2022.
- Historically, Inventory Average has averaged $223.2 million across 4 years, with a median of $224.7 million in 2023.
- Biggest five-year swings in Inventory Average: soared 63.09% in 2023 and later increased 23.34% in 2025.
- Year by year, Inventory Average stood at $109.8 million in 2022, then skyrocketed by 63.09% to $179.1 million in 2023, then soared by 50.98% to $270.3 million in 2024, then grew by 23.34% to $333.4 million in 2025.
- Business Quant data shows Inventory Average for ASND at $333.4 million in Q4 2025, $270.3 million in Q4 2024, and $179.1 million in Q4 2023.